Related Experiment Video
Updated: Jan 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Clinical Characteristics and Outcomes of Patients Admitted in Cardiac Intensive Care Unit with Cardiogenic Shock: A
Konstantinos C Siaravas1, Aidonis Rammos2, Aris Bechlioulis2
1First Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, Greece.
Insights
Cardiogenic shock (CS) has high mortality, especially in advanced SCAI stages. Improved clinical pathways and registries are crucial for better patient outcomes in this critical condition.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a severe condition characterized by inadequate tissue perfusion due to diminished cardiac output.
- Despite advancements, CS continues to have a high mortality rate.
Purpose of the Study:
- To investigate the clinical characteristics, management approaches, and patient outcomes of cardiogenic shock.
- To analyze short-term and long-term mortality in CS patients.
Main Methods:
- Prospective, single-center observational study of 70 patients (SCAI stages B-E) in a Cardiac Intensive Care Unit.
- Data collected included demographics, clinical status, hemodynamics, echocardiography, and biochemistry.
- Primary outcomes were in-hospital, 1-month, and 1-year mortality; secondary outcomes included mechanical circulatory support (MCS), mechanical ventilation (MV), and continuous renal replacement therapy (CRRT) use.
Main Results:
- Acute myocardial infarction-related CS (AMI-CS) and heart failure-related CS (HF-CS) comprised 64% of cases.
- Overall in-hospital mortality was 49%.
- Higher SCAI stage (C vs. B) independently predicted increased mortality. Elevated lactate, creatinine, and reduced cardiac output were key mortality predictors. IABP use was more common in AMI-CS.
Conclusions:
- Cardiogenic shock is associated with a poor prognosis, particularly in patients with higher SCAI stages.
- There is an urgent need for standardized clinical pathways and national registries to guide evidence-based care for CS.
Background:
Cardiogenic shock (CS) is a life threatening condition marked by inadequate tissue perfusion due to impaired cardiac output. Despite advances in diagnosis and management, mortality remains unacceptably high.
Objective:
This prospective, single-center observational study aimed to characterize the clinical profile, management strategies, and short- and long-term outcomes of patients with CS.
Methods:
Seventy patients (SCAI stages B-E) admitted to the Cardiac Intensive Care Unit (CICU) of a tertiary university hospital over a 24-month period were enrolled. Demographic, clinical, hemodynamic, echocardiographic, and biochemical data were collected. The primary outcomes were in-hospital, 1-month, and 1-year mortality. Secondary outcomes included the use of mechanical circulatory support (MCS), mechanical ventilation (MV), and continuous renal replacement therapy (CRRT).
Results:
Acute myocardial infarction-related CS (AMI-CS) and heart failure-related CS (HF-CS) accounted for 64% of cases. The overall in-hospital mortality was 49%. SCAI stage C was independently associated with higher mortality at all time points compared with stage B. Key predictors of mortality included higher SCAI stage, elevated lactate and creatinine levels, and reduced cardiac output. Intra-aortic balloon pump (IABP) use was more frequent in AMI-CS.
Conclusions:
CS continues to be associated with poor prognosis, particularly in patients with higher SCAI stages. Standardized clinical pathways and national registries are urgently needed to guide evidence-based and resource-appropriate care.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...